An Investigation into Potential Prognostic Indicators in a Large Cohort of Patients with Small Cell Lung Cancer (SCLC)

被引：0
|
作者：
Talbot, Thomas [1 ]
Bambury, Richard [2 ]
Henry, Michael [3 ]
Kennedy, Marcus [3 ]
机构：
[1] Univ Coll Cork, Sch Med, Cork, Ireland
[2] Cork Univ Hosp, Dept Med Oncol, Cork, Ireland
[3] Cork Univ Hosp, Dept Resp Med, Cork, Ireland
来源：
IRISH JOURNAL OF MEDICAL SCIENCE | 2019年 / 188卷 / SUPPL 12期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S365 / S365
页数：1
相关论文
共 50 条
  • [41] Update on the treatment of small cell lung cancer (SCLC)
    Ardizzoni, A
    Grossi, F
    ANNALS OF ONCOLOGY, 2000, 11 : 101 - 108
  • [42] Prognostic significance of C-KIT (CD 117) in small cell lung cancer (SCLC).
    Micke, P
    Hengstler, J
    Bittinger, F
    Faldum, A
    Rönnstrand, L
    Beeh, K
    Buhl, R
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3763S - 3763S
  • [43] Quality of Life and Cigarette Smoking of Small Cell Lung Cancer (SCLC) Patients
    Chen, Jun
    Qi, Yingwei
    Wampfler, Jason
    Jatoi, Aminah
    Garces, Yolanda I.
    Busta, Allan
    Mandrekar, Sumithra
    Yang, Ping
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S382 - S382
  • [44] Small cell lung cancer (SCLC) in the elderly: Retrospective review of 152 patients
    Maestu, I
    Pastor, M
    Gomez, J
    Aparicio, J
    Montalar, J
    Munarriz, B
    Reynes, G
    Herranz, C
    ANNALS OF ONCOLOGY, 1998, 9 : 103 - 103
  • [45] Analysis of long term survival patients with small cell lung cancer (SCLC)
    Bychkov, MB
    Gorbunova, VA
    Orel, NF
    2ND INTERNATIONAL CONGRESS ON LUNG CANCER, 1996, : 263 - 266
  • [46] Prognostic factors for response and survival of second-line chemotherapy in patients with relapsed small cell lung cancer (SCLC)
    Kim, Y.
    Goto, K.
    Yoh, K.
    Niho, S.
    Ohmatsu, H.
    Kubota, K.
    Saijo, N.
    Nishiwaki, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [47] MET in small cell lung carcinoma (SCLC): Effects of a MET inhibitor in SCLC cell lines and prognostic role of MET status in patients
    Canadas, I.
    Arumi, M.
    Lema, L.
    Martinez, A.
    Grande, E.
    Bellosillo, B.
    Rojo, F.
    Rovira, A.
    Albanell, J.
    Arriola, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [48] THE IMPACT OF EXTENSIVE INVESTIGATION ON THE MANAGEMENT OF PATIENTS WITH SMALL CELL LUNG-CARCINOMA (SCLC)
    FITZHARRIS, BM
    MCGEOCH, GRB
    COLLS, BM
    GUNN, DR
    WOLEVER, THS
    ATKINSON, CH
    ABDELAAL, AS
    NEW ZEALAND MEDICAL JOURNAL, 1985, 98 (790) : 962 - 962
  • [49] Gene mutations in small-cell lung cancer (SCLC): Results of a panel of 6 genes in a cohort of Italian patients
    Bordi, Paola
    Tiseo, Marcello
    Barbieri, Fausto
    Bavieri, Mario
    Sartori, Giuliana
    Marchetti, Antonio
    Buttitta, Fiamma
    Bortesi, Beatrice
    Ambrosini-Spaltro, Andrea
    Gnetti, Letizia
    Silini, Enrico Maria
    Ardizzoni, Andrea
    Rossi, Giulio
    LUNG CANCER, 2014, 86 (03) : 324 - 328
  • [50] Dyspnea as a Prognostic Factor in Hispanic Patients with Non-Small Cell Lung Cancer Cohort
    Campos-Gomez, S.
    Campos-Gomez, K. A.
    Valdes-Andrade, J. J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S871 - S871
12345